Compare McKesson Corporation (MCK) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Wolfspeed Inc — how do they compare? McKesson Corporation trades at $823.66 (market cap $97.35B), while Wolfspeed Inc trades at $31.39 (market cap $1.53B). The key difference: McKesson Corporation is far larger — about 63.6× Wolfspeed Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Wolfspeed Inc pays none. Which is the better fit depends on your goals.
| MCK | WOLF | |
|---|---|---|
Market Cap | $97.35B | $1.53B |
Sector | Health | Technology |
52-Week High | $995.69 | $73.68 |
52-Week Low | $659.01 | $1.19 |
Enterprise Value | $101.98B | $2.19B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
WOLF trades at $29.38, down 1.71% with bearish technical signals despite oversold RSI readings. The company shows negative profitability metrics with -79.83% net income margin and -14.54% ROE, though recent earnings beat expectations in two of three quarters. Strategic shifts toward data centers and defense markets alongside patent litigation activity create mixed sentiment.
Outlook remains challenging due to persistent losses and competitive pressures, though analyst consensus leans slightly bullish with 31.58% buy ratings. Key risks include execution on margin improvement and market share battles in the competitive semiconductor space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
